wegovy vs tirzepatide weight loss vs. Semaglutide: Which Works Better? Tirzepatide vs. Semaglutide for Weight

If the pattern follows other incretin therapies, weight regain after cessation is likely

Based on the estimated 3.8 million Part D enrollees eligible for the Medicare GLP-1 Bridge as of 2023, if 10% to 25% participate in Bridge from when the program launches in July 2026 and fill a prescription each month for the 18-month duration of the program, the cost to Medicare would be $1.3 billion to $3.3 billion (at a net monthly cost of $245 minus the $50 beneficiary copay)

If you have Health New Englands 3-Tier pharmacy plan option, you will see 3 copay amounts listed next to Pharmacy on your Member ID card see sample ID card below

It is not a Retatrutide prescription, reconstitution instruction, treatment schedule, or recommendation to use an investigational medication